V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20206514 | 20077231 | 1.68 | 85.3 | Curative (C) | 2018-07-03 | 2018-07-14 | Cisplatin +Fluorouracil (3 wk) | 02 | Y | CISPLATIN + FLUOROURACIL | 100161890 |
| 20206520 | 20077232 | 1.88 | 54.2 | Palliative (P) | 2018-09-01 | 2018-09-14 | Capecitabine (21days) + Carboplatin | 02 | null | CAPECITABINE + CARBOPLATIN | 100920775 |
| 20206521 | 20077233 | 1.73 | 68.4 | Palliative (P) | 2021-03-11 | 2021-03-24 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100727196 |
| 20206522 | 20077234 | 1.67 | 52 | Palliative (P) | 2017-03-03 | 2017-03-04 | Capecitabine (21days) + Carboplatin | N | null | CAPECITABINE + CARBOPLATIN | 100353126 |
| 20206523 | 20077235 | 1.8 | 79.8 | Curative (C) | 2017-04-11 | 2017-04-11 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101512421 |
| 20206525 | 20077236 | 1.65 | 71.9 | Palliative (P) | 2018-04-08 | 2018-04-17 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101529797 |
| 20206526 | 20077237 | 1.73 | null | Palliative (P) | 2019-04-17 | 2019-04-18 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100822113 |
| 20206533 | 20077238 | 1.73 | 53.6 | Palliative (P) | 2018-11-09 | 2018-11-23 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101199793 |
| 20206534 | 20077239 | 1.63 | 124 | Curative (C) | 2017-09-23 | 2017-10-14 | CISPLATIN + FLUOROURACIL | 02 | Y | CISPLATIN + FLUOROURACIL | 101278719 |
| 20206535 | 20077240 | 1.56 | 83 | null | 2017-06-05 | 2017-06-13 | Capecitabine (21days) + Carboplatin | 02 | null | TRIAL UNSPECIFIED | 100403091 |
| 20206536 | 20077241 | 1.82 | 83 | Curative (C) | 2018-06-10 | 2018-06-10 | Capecitabine (21days) + Carboplatin | N | Y | TRIAL UNSPECIFIED | 100219156 |
| 20206537 | 20077242 | 1.52 | 67 | Curative (C) | 2019-05-15 | 2019-05-15 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101398331 |
| 20206542 | 20077243 | null | null | Curative (C) | null | 2019-04-11 | CAPECITABINE + CARBOPLATIN | 02 | Y | DOXORUBICIN EMBOLISATION | 100734832 |
| 20206543 | 20077244 | null | 82.7 | Palliative (P) | 2022-05-04 | 2022-05-18 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100877744 |
| 20206545 | 20077245 | 0 | 0 | Palliative (P) | 2019-05-03 | 2019-05-08 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100754870 |
| 20206546 | 20077246 | 1.77 | 104 | Palliative (P) | 2016-01-28 | 2016-02-18 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100757014 |
| 20206551 | 20077247 | null | null | Neo-adjuvant (N) | 2020-08-23 | 2020-09-02 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100918268 |
| 20206553 | 20077248 | 1.66 | 80.4 | Neo-adjuvant (N) | 2018-01-23 | 2018-02-12 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100944159 |
| 20206554 | 20077249 | 0 | 0 | Palliative (P) | 2019-05-16 | 2019-05-17 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 100676164 |
| 20206567 | 20077250 | 1.62 | 52.3 | Adjuvant (A) | 2017-06-09 | 2017-06-21 | Cisplatin +Fluorouracil (3 wk) | 02 | null | CISPLATIN + FLUOROURACIL | 101021247 |
| 20206573 | 20077251 | 1.69 | 63.8 | Curative (C) | 2018-06-12 | 2018-06-17 | Capecitabine (21days) + Carboplatin | 02 | Y | CAPECITABINE + CARBOPLATIN | 100880042 |
| 20206576 | 20077252 | null | 91 | Curative (C) | 2018-03-10 | 2018-03-14 | CAPECITABINE + CARBOPLATIN | 02 | Y | CAPECITABINE + CARBOPLATIN | 100493509 |
| 20206577 | 20077253 | 1.69 | 96.1 | Curative (C) | 2018-02-19 | 2018-02-19 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101007628 |
| 20206578 | 20077254 | 1.72 | 79.6 | Neo-adjuvant (N) | 2017-05-28 | 2017-06-14 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100543256 |
| 20206579 | 20077255 | 1.69 | 95 | Curative (C) | 2016-06-29 | 2016-07-13 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100506023 |
| 20206580 | 20077256 | 1.59 | 74.1 | Neo-adjuvant (N) | 2019-08-12 | 2019-08-17 | Capecitabine + Carboplatin + RT | 02 | Y | CAPECITABINE + CARBOPLATIN | 100001396 |
| 20206581 | 20077257 | 0 | 0 | Curative (C) | 2019-08-03 | 2019-08-18 | Doxorubicin chemoembolisation | 02 | Y | DOXORUBICIN EMBOLISATION | 100761323 |
| 20206589 | 20077258 | 1.93 | 60.5 | Neo-adjuvant (N) | 2016-05-22 | 2016-05-22 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101466117 |
| 20206590 | 20077259 | 0 | 0 | Palliative (P) | 2017-07-05 | 2017-07-05 | CAPECITABINE + CARBOPLATIN | 02 | Y | DOXORUBICIN EMBOLISATION | 100303084 |
| 20206596 | 20077260 | 0 | 0 | Curative (C) | 2020-05-28 | 2020-06-28 | Doxorubicin chemoembolisation | N | N | DOXORUBICIN EMBOLISATION | 101390082 |
| 20206601 | 20077261 | 0 | 0 | Disease modification (D) | 2019-03-01 | 2019-03-11 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100900318 |
| 20206606 | 20077262 | 1.7 | 42 | Neo-adjuvant (N) | 2017-09-26 | 2017-10-01 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100308266 |
| 20206607 | 20077263 | 1.74 | 90.6 | null | 2017-08-19 | 2017-08-28 | Trial Unspecified | null | null | TRIAL UNSPECIFIED | 100322288 |
| 20206608 | 20077264 | 1.68 | 74 | Palliative (P) | 2017-03-02 | 2017-03-10 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100260366 |
| 20206609 | 20077265 | 1.79 | null | Neo-adjuvant (N) | 2016-12-01 | 2016-12-27 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 100647034 |
| 20206610 | 20077266 | 1.51 | 63.2 | Palliative (P) | 2018-10-01 | 2018-10-19 | Capecitabine + Carboplatin + RT | 02 | N | CISPLATIN + FLUOROURACIL | 100425571 |
| 20206613 | 20077267 | 1.61 | 70.7 | Palliative (P) | 2018-08-27 | 2018-09-03 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101525668 |
| 20206614 | 20077268 | 1.62 | 86.4 | Palliative (P) | 2020-01-31 | 2020-02-01 | Capecitabine (21days) + Carboplatin | 02 | N | CISPLATIN + FLUOROURACIL | 100172617 |
| 20206615 | 20077269 | 1.63 | 46.8 | Neo-adjuvant (N) | 2017-04-22 | 2017-04-22 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100560702 |
| 20206617 | 20077270 | null | null | null | 2018-04-23 | 2018-04-30 | Doxorubicin chemoembolisation | 99 | null | DOXORUBICIN EMBOLISATION | 101113344 |
| 20206619 | 20077271 | 1.8 | 67.2 | Curative (C) | 2017-07-06 | 2017-08-15 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 101584276 |
| 20206621 | 20077272 | 1.62 | 74.75 | Palliative (P) | 2020-01-05 | 2020-01-10 | CAPECITABINE + CARBOPLATIN | N | N | CAPECITABINE + CARBOPLATIN | 100546465 |
| 20206623 | 20077273 | 0 | 0 | null | null | 2019-12-24 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 100364578 |
| 20206624 | 20077274 | 1.6 | 72.5 | Curative (C) | 2019-07-24 | 2019-07-24 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101132221 |
| 20206626 | 20077275 | 1.6 | 64.1 | null | 2018-12-03 | 2018-12-12 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 101620309 |
| 20206627 | 20077276 | 1.55 | 88 | Palliative (P) | 2018-08-20 | 2018-09-27 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 101812064 |
| 20206628 | 20077277 | 1.6 | 57.3 | Neo-adjuvant (N) | 2018-06-01 | 2018-06-17 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101366328 |
| 20206629 | 20077278 | 1.59 | 72 | null | 2018-01-09 | 2018-01-09 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 100509823 |
| 20206633 | 20077279 | 1.59 | 81.9 | null | 2018-06-30 | 2018-07-01 | Doxorubicin chemoembolisation | N | null | DOXORUBICIN EMBOLISATION | 100639091 |
| 20206636 | 20077280 | 0 | 0 | Palliative (P) | 2018-05-23 | 2018-06-22 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100330689 |